Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study.

Grytten N, Myhr KM, Celius EG, Benjaminsen E, Kampman M, Midgard R, Vatne A, Aarseth JH, Riise T, Torkildsen Ø.

Mult Scler. 2019 Oct 1:1352458519877244. doi: 10.1177/1352458519877244. [Epub ahead of print]

PMID:
31573834
2.

Antiepileptic and psychiatric medication in a nationwide cohort of patients with glioma WHO grade II-IV.

Knudsen-Baas KM, Johannesen TB, Myklebust TÅ, Aarseth JH, Owe JF, Gilhus NE, Storstein AM.

J Neurooncol. 2018 Dec;140(3):739-748. doi: 10.1007/s11060-018-03007-9. Epub 2018 Nov 23.

PMID:
30471051
3.

Increased levels of cell-free mitochondrial DNA in the cerebrospinal fluid of patients with multiple sclerosis.

Varhaug KN, Vedeler CA, Myhr KM, Aarseth JH, Tzoulis C, Bindoff LA.

Mitochondrion. 2017 May;34:32-35. doi: 10.1016/j.mito.2016.12.003. Epub 2016 Dec 23.

PMID:
28017684
4.

The influence of coping styles on long-term employment in multiple sclerosis: A prospective study.

Grytten N, Skår AB, Aarseth JH, Assmus J, Farbu E, Lode K, Nyland HI, Smedal T, Myhr KM.

Mult Scler. 2017 Jun;23(7):1008-1017. doi: 10.1177/1352458516667240. Epub 2016 Sep 6.

PMID:
27600114
5.

Allelic imbalance of multiple sclerosis susceptibility genes IKZF3 and IQGAP1 in human peripheral blood.

Keshari PK, Harbo HF, Myhr KM, Aarseth JH, Bos SD, Berge T.

BMC Genet. 2016 Apr 14;17:59. doi: 10.1186/s12863-016-0367-4.

6.

The Norwegian Multiple Sclerosis Registry and Biobank.

Myhr KM, Grytten N, Torkildsen Ø, Wergeland S, Bø L, Aarseth JH.

Acta Neurol Scand. 2015;132(199):24-8. doi: 10.1111/ane.12427. Review.

PMID:
26046555
7.

A 60-year follow-up of the incidence and prevalence of multiple sclerosis in Hordaland County, Western Norway.

Grytten N, Aarseth JH, Lunde HM, Myhr KM.

J Neurol Neurosurg Psychiatry. 2016 Jan;87(1):100-5. doi: 10.1136/jnnp-2014-309906. Epub 2015 Feb 24.

8.

Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general.

Gustavsen MW, Viken MK, Celius EG, Berge T, Mero IL, Berg-Hansen P, Aarseth JH, Myhr KM, Søndergaard HB, Sellebjerg F, Oturai AB, Hillert J, Alfredsson L, Olsson T, Kockum I, Lie BA, Harbo HF.

J Neuroimmunol. 2014 Sep 15;274(1-2):174-9. doi: 10.1016/j.jneuroim.2014.06.024. Epub 2014 Jul 6.

PMID:
25037176
9.

Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study.

Olberg HK, Cox RJ, Nostbakken JK, Aarseth JH, Vedeler CA, Myhr KM.

Mult Scler. 2014 Jul;20(8):1074-80. doi: 10.1177/1352458513513970. Epub 2014 Jan 16.

PMID:
24436455
10.

Health related quality of life in patients recently diagnosed with multiple sclerosis.

Klevan G, Jacobsen CO, Aarseth JH, Myhr KM, Nyland H, Glad S, Lode K, Figved N, Larsen JP, Farbu E.

Acta Neurol Scand. 2014 Jan;129(1):21-6. doi: 10.1111/ane.12142. Epub 2013 Jun 15.

PMID:
23772958
11.

Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles.

Mero IL, Gustavsen MW, Sæther HS, Flåm ST, Berg-Hansen P, Søndergaard HB, Jensen PE, Berge T, Bjølgerud A, Muggerud A, Aarseth JH; International Multiple Sclerosis Genetics Consortium, Myhr KM, Celius EG, Sellebjerg F, Hillert J, Alfredsson L, Olsson T, Oturai AB, Kockum I, Lie BA, Andreassen BK, Harbo HF.

PLoS One. 2013;8(3):e58352. doi: 10.1371/journal.pone.0058352. Epub 2013 Mar 5.

12.

Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway.

Kampman MT, Aarseth JH, Grytten N, Benjaminsen E, Celius EG, Dahl OP, Holmøy T, Løken-Amsrud K, Midgard R, Myhr KM, Risberg G, Vatne A, Torkildsen O.

J Neurol. 2013 Jun;260(6):1481-8. doi: 10.1007/s00415-012-6814-x. Epub 2013 Jan 6.

PMID:
23292231
13.

Health-related quality of life and disease-modifying treatment behaviour in relapsing-remitting multiple sclerosis--a multicentre cohort study.

Grytten N, Aarseth JH, Espeset K, Berg Johnsen G, Wehus R, Lund C, Riise T, Haugstad R.

Acta Neurol Scand Suppl. 2012;(195):51-7. doi: 10.1111/ane.12033.

PMID:
23278657
14.

The Norwegian Multiple Sclerosis Registry and Biobank.

Myhr KM, Grytten N, Aarseth JH.

Acta Neurol Scand Suppl. 2012;(195):20-3. doi: 10.1111/ane.12030.

PMID:
23278652
15.

A need for national registries and international collaborative research in multiple sclerosis.

Myhr KM, Grytten N, Torkildsen Ø, Wergeland S, Bø L, Pugliatti M, Aarseth JH.

Acta Neurol Scand Suppl. 2012;(195):1-3. doi: 10.1111/ane.12039.

PMID:
23278648
16.

Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway.

Grytten N, Torkildsen Ø, Aarseth JH, Benjaminsen E, Celius EG, Dahl OP, Holmøy T, Løken-Amsrud K, Midgard R, Myhr KM, Risberg G, Vatne A, Kampman MT.

Mult Scler. 2013 Jul;19(8):1028-34. doi: 10.1177/1352458512471094. Epub 2012 Dec 20.

PMID:
23257620
17.

Stoppers and non-starters of disease-modifying treatment in multiple sclerosis.

Grytten N, Aarseth JH, Espeset K, Johnsen GB, Wehus R, Lund C, Haugstad RC.

Acta Neurol Scand. 2013 Feb;127(2):133-40. doi: 10.1111/j.1600-0404.2012.01708.x. Epub 2012 Aug 25.

PMID:
22924678
18.

Polymorphisms of the BDNF gene show neither association with multiple sclerosis susceptibility nor clinical course.

Mero IL, Smestad C, Lie BA, Lorentzen ÅR, Sandvik L, Landrø NI, Aarseth JH, Myhr KM, Celius EG, Harbo HF.

J Neuroimmunol. 2012 Mar;244(1-2):107-10. doi: 10.1016/j.jneuroim.2012.01.011. Epub 2012 Feb 15.

PMID:
22341604
19.

Risk of MS is not associated with exposure to crude oil, but increases with low level of education.

Riise T, Kirkeleit J, Aarseth JH, Farbu E, Midgard R, Mygland Å, Eikeland R, Mørland TJ, Telstad W, Førland PT, Myhr KM.

Mult Scler. 2011 Jul;17(7):780-7. doi: 10.1177/1352458510397686. Epub 2011 Feb 22.

PMID:
21343231
20.

Prevalence and incidence of multiple sclerosis in Oppland County: a cross-sectional population-based study in a landlocked county of Eastern Norway.

Risberg G, Aarseth JH, Nyland H, Lauer K, Myhr KM, Midgard R.

Acta Neurol Scand. 2011 Oct;124(4):250-7. doi: 10.1111/j.1600-0404.2010.01465.x. Epub 2010 Dec 10.

PMID:
21143594
21.

The cost of multiple sclerosis in Norway.

Svendsen B, Myhr KM, Nyland H, Aarseth JH.

Eur J Health Econ. 2012 Feb;13(1):81-91. doi: 10.1007/s10198-010-0286-7. Epub 2010 Nov 16.

22.

How long can you keep working with benign multiple sclerosis?

Glad SB, Nyland H, Aarseth JH, Riise T, Myhr KM.

J Neurol Neurosurg Psychiatry. 2011 Jan;82(1):78-82. doi: 10.1136/jnnp.2010.210732. Epub 2010 Aug 27.

PMID:
20802029
23.

Association to the Glypican-5 gene in multiple sclerosis.

Lorentzen AR, Melum E, Ellinghaus E, Smestad C, Mero IL, Aarseth JH, Myhr KM, Celius EG, Lie BA, Karlsen TH, Franke A, Harbo HF.

J Neuroimmunol. 2010 Sep 14;226(1-2):194-7. doi: 10.1016/j.jneuroim.2010.07.003. Epub 2010 Aug 6.

PMID:
20692050
24.

The influence of warm versus cold climate on the effect of physiotherapy in multiple sclerosis.

Smedal T, Myhr KM, Aarseth JH, Gjelsvik B, Beiske AG, Glad SB, Strand LI.

Acta Neurol Scand. 2011 Jul;124(1):45-52. doi: 10.1111/j.1600-0404.2010.01407.x. Epub 2010 Jul 15.

PMID:
20636448
25.

Benign multiple sclerosis: a need for a consensus.

Glad SB, Aarseth JH, Nyland H, Riise T, Myhr KM.

Acta Neurol Scand Suppl. 2010;(190):44-50. doi: 10.1111/j.1600-0404.2010.01375.x.

PMID:
20586735
26.

Fatigue in multiple sclerosis: associations with health-related quality of life and physical performance.

Smedal T, Beiske AG, Glad SB, Myhr KM, Aarseth JH, Svensson E, Gjelsvik B, Strand LI.

Eur J Neurol. 2011 Jan;18(1):114-20. doi: 10.1111/j.1468-1331.2010.03090.x.

PMID:
20491899
27.

A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis.

Mero IL, Lorentzen AR, Ban M, Smestad C, Celius EG, Aarseth JH, Myhr KM, Link J, Hillert J, Olsson T, Kockum I, Masterman T, Oturai AB, Søndergaard HB, Sellebjerg F, Saarela J, Kemppinen A, Elovaara I, Spurkland A, Dudbridge F, Lie BA, Harbo HF.

Eur J Hum Genet. 2010 Apr;18(4):502-4. doi: 10.1038/ejhg.2009.195. Epub 2009 Nov 4.

28.

Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway.

Glad SB, Nyland HI, Aarseth JH, Riise T, Myhr KM.

Mult Scler. 2009 Aug;15(8):942-50. doi: 10.1177/1352458509106511. Epub 2009 Jul 1.

PMID:
19570821
29.

Onconeural antibodies in sera from patients with various types of tumours.

Monstad SE, Knudsen A, Salvesen HB, Aarseth JH, Vedeler CA.

Cancer Immunol Immunother. 2009 Nov;58(11):1795-800. doi: 10.1007/s00262-009-0690-y. Epub 2009 Mar 18.

PMID:
19294382
30.

Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway.

Grytten Torkildsen N, Lie SA, Aarseth JH, Nyland H, Myhr KM.

Mult Scler. 2008 Nov;14(9):1191-8. doi: 10.1177/1352458508093890. Epub 2008 Jul 16.

PMID:
18632781
31.

Depression and anxiety amongst multiple sclerosis patients.

Beiske AG, Svensson E, Sandanger I, Czujko B, Pedersen ED, Aarseth JH, Myhr KM.

Eur J Neurol. 2008 Mar;15(3):239-45. doi: 10.1111/j.1468-1331.2007.02041.x. Epub 2008 Jan 22.

PMID:
18215155
32.

Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey.

Haldorsen IS, Krossnes BK, Aarseth JH, Scheie D, Johannesen TB, Mella O, Espeland A.

Cancer. 2007 Oct 15;110(8):1803-14.

33.

CRMP5 antibodies in patients with small-cell lung cancer or thymoma.

Monstad SE, Drivsholm L, Skeie GO, Aarseth JH, Vedeler CA.

Cancer Immunol Immunother. 2008 Feb;57(2):227-32. Epub 2007 Jul 27.

PMID:
17657489
34.

Focal epileptiform activity described by a large computerised EEG database.

Aurlien H, Aarseth JH, Gjerde IO, Karlsen B, Skeidsvoll H, Gilhus NE.

Clin Neurophysiol. 2007 Jun;118(6):1369-76. Epub 2007 Apr 23.

PMID:
17452009
35.

Health-related quality of life in secondary progressive multiple sclerosis.

Beiske AG, Naess H, Aarseth JH, Andersen O, Elovaara I, Farkkila M, Hansen HJ, Mellgren SI, Sandberg-Wollheim M, Sorensen PS, Myhr KM; Nordic SPMS study group.

Mult Scler. 2007 Apr;13(3):386-92.

PMID:
17439908
36.

The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases.

Tzoulis C, Engelsen BA, Telstad W, Aasly J, Zeviani M, Winterthun S, Ferrari G, Aarseth JH, Bindoff LA.

Brain. 2006 Jul;129(Pt 7):1685-92. Epub 2006 Apr 25.

PMID:
16638794
37.
38.

Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation technique.

Monstad SE, Storstein A, Dørum A, Knudsen A, Lønning PE, Salvesen HB, Aarseth JH, Vedeler CA.

Clin Exp Immunol. 2006 Apr;144(1):53-8.

39.

A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway.

Grytten N, Glad SB, Aarseth JH, Nyland H, Midgard R, Myhr KM.

Neurology. 2006 Jan 24;66(2):182-6.

PMID:
16434650
40.

Ri antibodies in patients with breast, ovarian or small cell lung cancer determined by a sensitive immunoprecipitation technique.

Knudsen A, Monstad SE, Dørum A, Lønning PE, Salvesen HB, Drivsholm L, Aarseth JH, Vedeler CA.

Cancer Immunol Immunother. 2006 Oct;55(10):1280-4. Epub 2006 Jan 21.

PMID:
16429314
41.

High dose methylprednisolone induces FcgammaRI on granulocytes in MS-patients.

Torkildsen O, Vedeler CA, Ulvestad E, Aarseth JH, Nyland HI, Myhr KM.

J Neuroimmunol. 2005 Oct;167(1-2):138-42.

PMID:
16002152
42.

Fcgamma receptor IIIA polymorphism as a risk-factor for coronary artery disease.

Gavasso S, Nygård O, Pedersen ER, Aarseth JH, Bleie O, Myhr KM, Vedeler CA.

Atherosclerosis. 2005 Jun;180(2):277-82. Epub 2005 Jan 25.

PMID:
15910853
43.

Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway.

Salvesen Haldorsen I, Aarseth JH, Hollender A, Larsen JL, Espeland A, Mella O.

Acta Oncol. 2004;43(6):520-9.

PMID:
15370608
44.

Multiple sclerosis in Nord-Trøndelag County, Norway: a prevalence and incidence study.

Dahl OP, Aarseth JH, Myhr KM, Nyland H, Midgard R.

Acta Neurol Scand. 2004 Jun;109(6):378-84.

PMID:
15147459
45.

EEG background activity described by a large computerized database.

Aurlien H, Gjerde IO, Aarseth JH, Eldøen G, Karlsen B, Skeidsvoll H, Gilhus NE.

Clin Neurophysiol. 2004 Mar;115(3):665-73.

PMID:
15036063
46.

Hu and voltage-gated calcium channel (VGCC) antibodies related to the prognosis of small-cell lung cancer.

Monstad SE, Drivsholm L, Storstein A, Aarseth JH, Haugen M, Lang B, Vincent A, Vedeler CA.

J Clin Oncol. 2004 Mar 1;22(5):795-800.

PMID:
14990634
47.
48.

Interleukin-10 promoter polymorphisms in patients with Guillain-Barré syndrome.

Myhr KM, Vågnes KS, Marøy TH, Aarseth JH, Nyland HI, Vedeler CA.

J Neuroimmunol. 2003 Jun;139(1-2):81-3.

PMID:
12799024
49.

Interleukin-10 promoter polymorphisms in patients with multiple sclerosis.

Myhr KM, Vågnes KS, Marøy TH, Aarseth JH, Nyland HI, Vedeler CA.

J Neurol Sci. 2002 Oct 15;202(1-2):93-7.

PMID:
12220699

Supplemental Content

Loading ...
Support Center